Home / Industry News / 2012 / Anti-counterfeit Market on Path to Strong Growth

Anti-counterfeit Market on Path to Strong Growth

Source: PharmaManufacturing.com

Oct 31, 2012

SecuringIndustry.com

Show More Content

More News:

Anti-vaxxers turn to potatoes

04/19/2019

A new and weird rumor has surfaced in the anti-vaccine movement: potatoes can suck the toxins from vaccines out of your kids' arms.
Low dose Pfizer-Lilly painkiller fails late stage study

04/19/2019

A lower dose of non-opioid painkiller, tanezumab, developed by Pfizer and Eli Lilly failed to meet main goals in a late-stage study in patients with moderate-to-severe osteoarthritis.
Amgen launches "Biotech Experience" program in Florida

04/18/2019

The Amgen Foundation has teamed with the University of South Florida to launch the Amgen Biotech Experience (ABE) program, designed to give students hands-on biotechnology lab experience.
Chinese pharma plant explosion kills 10

04/17/2019

At least 10 people have died from smoke inhalation at a manufacturing plant in China owned by a large pharmaceutical company.
FDA warns drugmaker after bacteria found in facility water

04/17/2019

The FDA has issued a warning letter to RIJ Pharmaceutical following an inspection that uncovered unacceptable levels of three bacteria in water used in operations.
Novartis nabs FDA priority review for potential eye blockbuster

04/16/2019

If approved this will have the drugmaker go head to head against Roche’s Lucentis and Regeneron’s Eylea
Gilead partners with insitro for experimental liver meds

04/16/2019

The company is paying insitro $15 million upfront with additional near-term payments up to $35 million based on operational milestones
Sanofi MS drug under safety review in the EU for dangerous side effects

04/15/2019

The European Medicines Agency is taking a closer look at safety issues linked to the use of a Sanofi multiple sclerosis drug, Lemtrada.
Allergan loses Supreme Court fight to shield Restasis patents with Native American tribe

04/15/2019

The U.S. Supreme Court has rejected Allergan’s attempt to protect drug patents by transferring them a Native American tribe.
Catalent to buy gene therapy CDMO for $1.2 billion

04/15/2019

Contract drug manufacturer Catalent has agreed to acquire Paragon Bioservices for in $1.2 billion in cash, to help expand its gene-therapy manufacturing capabilities.

All news

Pharma Manufacturing

Anti-counterfeit Market on Path to Strong Growth

Anti-vaxxers turn to potatoes

A new and weird rumor has surfaced in the anti-vaccine movement: potatoes…

Allergan loses Supreme Court fight to shield Restasis patents with Native American tribe

The U.S. Supreme Court has rejected Allergan’s attempt to protect drug…

Reliving biotech’s most shocking scandal — the story of Theranos

The biggest case of fraud in biotech history is getting its day in the…

Chinese pharma plant explosion kills 10

At least 10 people have died from smoke inhalation at a manufacturing…

Sanofi MS drug under safety review in the EU for dangerous side effects

The European Medicines Agency is taking a closer look at safety issues…

Apotex reportedly looking at sale as investigation of CEO death continues

Nearly a year and a half after the death of Apotex’s founder and CEO and…

Anti-vaxxers turn to potatoes

A new and weird rumor has surfaced in the anti-vaccine movement: potatoes…

AbbVie announces Stemcentrx layoffs

AbbVie will eliminate 178 jobs from its Stemcentrx unit in San Francisco,…

Merck KGaA gets FDA nod for MS med

The U.S. FDA has approved EMD Serono's Mavenclad tablets for the treatment…

Heritage Pharma files lawsuit after drug shipment knocked into a river

New Jersey-based Heritage Pharmaceuticals is seeking damages from a Port…

Top Pharma Manufacturing Predictions for 2019

From new tech to innovative business models and shifting regulations,…

Top 5 Drugs With the Biggest Growth Potential in 2019

In the coming year, several drugs that treat a range of diseases will far…

The Highest — and Lowest — Ranked Places to Work in Big Pharma

How pharma companies fair on Glassdoor.

Boehringer cuts nearly 300 jobs in France

The company's French workforce will see 327 jobs cut but will also see 32…

FDA slaps Akorn plant with Form 483

The regulatory body found issues at the drugmaker's New Jersey site,…